UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1943-01-01

Employees: 8.1K

Market Cap: -

Website: http://www.utsouthwestern.edu

Clinical Trials

Identification and Treatment of Clinically Silent Catheter-Related Deep Vein Thrombosis in Children With Cancer

Phase 2

Terminated

Conditions: Central Venous Catheters
Catheter-related Occlusion
Deep Vein Thrombosis
Childhood Cancer
Catheter-related Infection

Interventions: Drug: Enoxaparin

First Posted Date: 2008-03-11

Last Posted Date: 2020-10-08

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 136

Registration Number: NCT00633061

Locations: 🇺🇸
Children's Medical Center, Dallas, Texas, United States

Safety Study of ACP-104: To Demonstrate the Safety, Tolerability, and Pharmacokinetics

Phase 1

Completed

Conditions: Schizophrenia

Interventions: Drug: ACP-104
Drug: Placebo

First Posted Date: 2008-03-05

Last Posted Date: 2011-06-28

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 45

Registration Number: NCT00628420

Locations: 🇺🇸
The University of Texas Southwestern Medical Center, Dallas, Texas, United States
🇺🇸
Veteran's Affairs Medical Center, Dallas, Texas, United States

Treating Cognition in Schizophrenia With Atomoxetine and Cognitive Remediation

Phase 4

Completed

Conditions: Cognition in Schizophrenia

Interventions: Drug: Atomoxetine
Drug: Placebo

First Posted Date: 2008-03-05

Last Posted Date: 2020-09-25

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 119

Registration Number: NCT00628394

Locations: 🇺🇸
The University of Texas Southwestern Medical Center, Dallas, Texas, United States

Trial of Vasopressin and Epinephrine to Epinephrine Only for In-Hospital Pediatric Cardiopulmonary Resuscitation

Phase 1

Completed

Conditions: Cardiac Arrest
Cardiopulmonary Arrest

Interventions: Drug: Vasopressin
Drug: Epinephrine

First Posted Date: 2008-03-05

Last Posted Date: 2019-09-17

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 130

Registration Number: NCT00628550

Locations: 🇺🇸
Universtity of Texas Southwestern, Children's Medical Center, Dallas, Texas, United States

Pharmacokinetics of Linezolid in Children With Cystic Fibrosis

Phase 2

Completed

Conditions: Cystic Fibrosis

Interventions: Drug: Linezolid

First Posted Date: 2008-02-28

Last Posted Date: 2020-03-27

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 45

Registration Number: NCT00625703

Locations: 🇺🇸
University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States

Sorafenib and Paclitaxel in Treating Patients With Metastatic Breast Cancer

Phase 2

Terminated

Conditions: Breast Cancer

Interventions: Drug: paclitaxel
Drug: sorafenib tosylate

First Posted Date: 2008-02-25

Last Posted Date: 2020-10-19

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 20

Registration Number: NCT00622466

Locations: 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States

Treatment of Outpatients With Severe Asthma and Moderate or Severe Major Depressive Disorder

Phase 4

Completed

Conditions: Severe Asthma
Moderate or Severe Major Depressive Disorder

Interventions: Drug: Placebo
Drug: Escitalopram

First Posted Date: 2008-02-22

Last Posted Date: 2014-02-04

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 26

Registration Number: NCT00621946

Locations: 🇺🇸
The UT Southwestern Medical Center at Dallas, Dallas, Texas, United States

The Efficacy of Hand Narrow-Band Ultraviolet B (NBUVB) Versus Excilite Treatment in Vitiligo After Minigrafting on the Dorsal Hands

Not Applicable

Completed

Conditions: Vitiligo

Interventions: Device: Monochromacitc Excimer light
Device: NBUVB

First Posted Date: 2008-02-22

Last Posted Date: 2019-11-05

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 13

Registration Number: NCT00622180

Locations: 🇺🇸
UT Southwestern Medical Center at Dallas - Dermatology Clinical Trials, Dallas, Texas, United States

Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma

Phase 2

Withdrawn

Conditions: Lymphoproliferative Disorder
Small Intestine Cancer
Brain and Central Nervous System Tumors
Lymphoma

Interventions: Biological: autologous immunoglobulin idiotype-KLH conjugate vaccine
Biological: sargramostim
Drug: methotrexate
Drug: thiotepa
Radiation: radiation therapy

First Posted Date: 2008-02-22

Last Posted Date: 2018-11-26

Lead Sponsor: University of Texas Southwestern Medical Center

Registration Number: NCT00621036

Locations: 🇺🇸
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas, Texas, United States

Citicoline for Bipolar 1 Disorder and Cocaine Dependence

Phase 4

Completed

Conditions: Bipolar Disorder
Cocaine Dependence

Interventions: Drug: Citicoline
Drug: Placebo
Behavioral: Cognitive Behavioral Therapy (CBT)

First Posted Date: 2008-02-21

Last Posted Date: 2018-01-24

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 130

Registration Number: NCT00619723

Locations: 🇺🇸
Exchange Park Center, American General Building (Bass)- PNE: FL8, STE 828, Dallas, Texas, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy